U.S. market Closed. Opens in 2 hours 21 minutes

PMCB | PharmaCyte Biotech, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.7000 - 1.8652
52 Week Range 1.3900 - 2.5800
Beta -0.10
Implied Volatility 454.10%
IV Rank 91.11%
Day's Volume 6,677
Average Volume 35,246
Shares Outstanding 7,679,050
Market Cap 13,207,966
Sector Healthcare
Industry Biotechnology
IPO Date 2013-01-02
Valuation
Profitability
Growth
Health
P/E Ratio 2.69
Forward P/E Ratio N/A
EPS 0.64
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 2
Country USA
Website PMCB
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
*Chart delayed
Analyzing fundamentals for PMCB we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is very wealthy, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see PMCB Fundamentals page.

Watching at PMCB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PMCB Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙